Obama and Democratic congress sorely underfund health guardian
The U.S. Food and Drug Administration
WASHINGTON, D.C. — The U.S. Food and Drug Administration, which regulates products that account for 25 cents of every dollar spent by a consumer, always is engaged in controversy.
Some critics say that new drugs are approved too quickly and therefore are not adequately tested, while others say that delays in approving new drugs cost lives. Some say that our food supply is safe, others point to episodes where unsafe foods have entered the market. Some say the FDA should take more aggressive enforcement actions, others say that the FDA should rely more on voluntary compliance by companies.
There’s one thing that everyone agrees on, though, and that is the FDA is underfunded and needs more money to do its job properly. This is a consensus held by patient organizations, consumer and research groups, the professional community, and all the industries regulated by the FDA.
Consider this anecdote from a report presented to the FDA by its own science committee: the FDA had to bring back retired computer experts to repair its servers, because they were so old and out of date, the younger repairmen did not know how to fix them. True story!
Or consider that FDA inspects less than one percent of the food that is imported into the U.S. each year, and sometimes goes for many years without inspecting facilities where prescription drugs and medical devices are made.
FDA has as many employees as it had in 2004, but since then Congress has given it the Congress much more responsibility. Considers these points:
- For example, the FDA has been given new responsibility to establish more modern systems to gather and evaluate adverse drug reactions, but there is no added money to do so.
- The FDA was assigned by the Congress to regulate tobacco products, and can charge fees to the tobacco manufacturers, but the fees can’t cover the time needed to oversee the activities at the most senior levels of the agency.
- And if a healthcare reform bill passes, FDA is likely to have, without added funds, still more responsibility to regulate, for example, generic versions of biotech drug products.
Read next: Congress Adds Pay Raise and Obamacare Exemption in Spending Bill
Email Us | Reader Friendly | Comments
Guest Column——Bio and Archives
Items of notes and interest from the web.
